Wealth Enhancement Advisory Services’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
11,300
+2,218
+24% +$269K ﹤0.01% 1878
2026
Q1
$1.48M Sell
9,082
-1,345
-13% -$207K ﹤0.01% 1552
2025
Q4
$1.83M Buy
10,427
+2,829
+37% +$516K ﹤0.01% 1564
2025
Q3
$1.23M Buy
7,598
+3,152
+71% +$386K ﹤0.01% 1733
2025
Q2
$435K Buy
4,446
+674
+18% +$51.5K ﹤0.01% 2325
2025
Q1
$288K Buy
3,772
+541
+17% +$41.4K ﹤0.01% 2478
2024
Q4
$223K Buy
3,231
+307
+10% +$22.1K ﹤0.01% 2619
2024
Q3
$213K Sell
2,924
-899
-24% -$66.3K ﹤0.01% 2409
2024
Q2
$256K Buy
+3,823
New +$148K ﹤0.01% 2098

Other funds holding INSM

Wealth Enhancement Advisory Services's INSM Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Insmed (INSM) stake by 24% in Q2 2026, buying an estimated $269K and bringing the position to 11,300 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1878.

Wealth Enhancement Advisory Services first reported a position in INSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.83M in Q4 2025. 106 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Wealth Enhancement Advisory Services held 11,300 shares of Insmed worth $1.31M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 2,218 Insmed shares in Q2 2026, an estimated $269K.
  • Insmed made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #1878 holding.
  • Wealth Enhancement Advisory Services first reported a position in Insmed in Q2 2024 and has held it in 9 quarters since.
  • Wealth Enhancement Advisory Services's Insmed position peaked at $1.83M in Q4 2025.
  • 106 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.